Cargando…

P383: THE NEXT-GENERATION SEQUENCING (NGS) BASED MRD ASSESSMENT COULD BETTER PREDICT RELAPSE THAN MULTIPARAMETER FLOW CYTOMETRY (MFC) IN ADULT B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA

Detalles Bibliográficos
Autores principales:	Yan, Nan, Zhou, Ya-Lan, Zhao, Ming-Yue, Liao, Ming-Yue, Wang, Chun-Yang, Wang, Xiao-Juan, Zhu, Jian-Hua, Jiang, Hao, Jiang, Qian, Chang, Ying-Jun, Xu, Lan-Ping, Zhang, Xiao-Hui, Huang, Xiao-Jun, Ruan, Guo-Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428258/ http://dx.doi.org/10.1097/01.HS9.0000968440.65226.ed

Ejemplares similares

Comparison of NGS and MFC Methods: Key Metrics in Multiple Myeloma MRD Assessment
por: Kriegsmann, Katharina, et al.
Publicado: (2020)

Effects of isolated central nervous system involvement evaluated by multiparameter flow cytometry prior to allografting on outcomes of patients with acute lymphoblastic leukemia
por: Ma, Ling, et al.
Publicado: (2023)

Measurable Residual Disease Detected by Multiparameter Flow Cytometry and Sequencing Improves Prediction of Relapse and Survival in Acute Myeloid Leukemia
por: Liu, Fu-Jia, et al.
Publicado: (2021)

NGS better discriminates true MRD positivity for the risk stratification of childhood ALL treated on an MRD-based protocol
por: Svaton, Michael, et al.
Publicado: (2023)

Preanalytical conditions for multiparameter platelet flow cytometry
por: Hindle, Matthew S., et al.
Publicado: (2023)

MFC programming
por: Feuer, Alan R
Publicado: (1997)

Diagnosis of Acute Leukemia by Multiparameter Flow Cytometry with the Assistance of Artificial Intelligence
por: Zhong, Pengqiang, et al.
Publicado: (2022)

Multiparameter Flow Cytometry: Advances in High Resolution Analysis
por: O'Donnell, Erika A, et al.
Publicado: (2013)

Value of flow cytometry for MRD-based relapse prediction in B-cell precursor ALL in a multicenter setting
por: Modvig, S., et al.
Publicado: (2020)

Monitoring of population dynamics of Corynebacterium glutamicum by multiparameter flow cytometry
por: Neumeyer, Andrea, et al.
Publicado: (2013)

Current applications of multiparameter flow cytometry in plasma cell disorders
por: Jelinek, T, et al.
Publicado: (2017)

Current applications of multiparameter flow cytometry in plasma cell disorders
por: Jelinek, T, et al.
Publicado: (2018)

A Triple Staining Method for Accurate Cell Cycle Analysis Using Multiparameter Flow Cytometry
por: Qiu, Lin, et al.
Publicado: (2013)

Measurable Residual Disease (MRD) by Flow Cytometry in Adult B-Acute Lymphoblastic Leukaemia (B-ALL) and Acute Myeloid Leukaemia (AML): Correlation with Molecular MRD Testing and Clinical Outcome at One Year
por: van der Linde, Riana, et al.
Publicado: (2023)

Survival outcomes in patients with relapsed/refractory or MRD-positive B-cell acute lymphoblastic leukemia treated with blinatumomab
por: Kantarjian, Hagop M., et al.
Publicado: (2023)

Vidjil add‐on for MRD quantification of samples processed using the EuroClonality‐NGS protocol
por: Giusti, Guilherme Navarro Nilo, et al.
Publicado: (2023)

Utility of flow cytometry screening before MRD testing in multiple myeloma
por: Panakkal, Vandana, et al.
Publicado: (2023)

Potential and pitfalls of whole transcriptome-based immunogenetic marker identification in acute lymphoblastic leukemia; a EuroMRD and EuroClonality-NGS Working Group study
por: van der Velden, Vincent H. J., et al.
Publicado: (2021)

Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis
por: Chang, Ying-Jun, et al.
Publicado: (2017)

MRD Monitoring by Multiparametric Flow Cytometry in AML: Is It Time to Incorporate Immune Parameters?
por: Pessach, Ilias, et al.
Publicado: (2022)

P889: WILL OUTCOME IMPROVE BY TREATING MULTIPLE MYELOMA PATIENTS AT MRD RELAPSE? THE REMNANT STUDY (RELAPSE FROM MRD NEGATIVITY AS INDICATION FOR TREATMENT)
por: Askeland, F. B., et al.
Publicado: (2022)

Minimal residual disease (MRD) detection in acute lymphoblastic leukaemia based on fusion genes and genomic deletions: towards MRD for all
por: Kuiper, Roland P., et al.
Publicado: (2021)

Standardized next-generation sequencing of immunoglobulin and T-cell receptor gene recombinations for MRD marker identification in acute lymphoblastic leukaemia; a EuroClonality-NGS validation study
por: Brüggemann, Monika, et al.
Publicado: (2019)

Contribution of Multiparameter Flow Cytometry Immunophenotyping to the Diagnostic Screening and Classification of Pediatric Cancer
por: Ferreira-Facio, Cristiane S., et al.
Publicado: (2013)

Multiparametric Flow Cytometry for MRD Monitoring in Hematologic Malignancies: Clinical Applications and New Challenges
por: Riva, Giovanni, et al.
Publicado: (2021)

Cysteine and glycine-rich protein 2 (CSRP2) transcript levels correlate with leukemia relapse and leukemia-free survival in adults with B-cell acute lymphoblastic leukemia and normal cytogenetics
por: Wang, Shu-Juan, et al.
Publicado: (2017)

CSRP2 transcript levels after consolidation therapy increase prognostic prediction ability in B-cell acute lymphoblastic leukemia
por: Cao, Lei-Ming, et al.
Publicado: (2023)

Robust MFC anti-windup scheme for LTI systems with norm-bounded uncertainty
por: Mo, Xiao-Qin, et al.
Publicado: (2021)

Baseline VDJ clonotype detection using a targeted sequencing NGS assay: allowing for subsequent MRD assessment
por: Hultcrantz, Malin, et al.
Publicado: (2020)

Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
por: Larribère, Lionel, et al.
Publicado: (2021)

Pretransplant FLT3-ITD MRD assessed by high-sensitivity PCR-NGS determines posttransplant clinical outcome
por: Loo, Sun, et al.
Publicado: (2022)

The influence of electrode spacing on the performance of bioretention cell coupled with MFC
por: Ya-Jun, Wang, et al.
Publicado: (2021)

Extending the MFC library : add useful reusable features to the Microsoft foundation class library
por: Schmitt, David A.
Publicado: (1996)

Minimal residual disease assessment in acute lymphoblastic leukemia by 4-color flow cytometry: Recommendations from the MRD Working Group of the Brazilian Society of Bone Marrow Transplantation
por: Ikoma-Colturato, Maura R.V., et al.
Publicado: (2021)

Lyoplate-based multiparameter flow cytometry for the analysis of T cell subsets in human immuno-monitoring studies
por: Villanova, Federica, et al.
Publicado: (2011)

Identifying Leukemia-associated Immunophenotypes in Acute Myeloid Leukemia Patients Using Multiparameter Flow Cytometry
por: Rasheed, Hadeer Mohamed, et al.
Publicado: (2021)

Advanced Immune Cell Profiling by Multiparameter Flow Cytometry in Humanized Patient-Derived Tumor Mice
por: Bruss, Christina, et al.
Publicado: (2022)

P1263: A SENSITIVE NGS ASSAY TO DETECT MEASURABLE RESIDUAL DISEASE (MRD) IN B-CELL LYMPHOPROLIFERATIVE DISEASES
por: Hebert, L., et al.
Publicado: (2022)

NGS-defined measurable residual disease (MRD) after initial chemotherapy as a prognostic biomarker for acute myeloid leukemia
por: Li, Yonghong, et al.
Publicado: (2023)

PB1781: THE APPLICATION OF CF-DNA FOR NGS MRD STUDIES IN PATIENTS WITH LMA IMPROVES THE SENSITIVITY OF THE METHOD WITH RESPECT TO CTC.
por: Sánchez-Redondo, Noemí Álvarez, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ekmc0daail8cjp8apkkvp967qn